Yohimban-16-carboxylic acid,17-hydroxy-,methyl ester,(16R,17R)-,mixt. with (2R)-3,4-dihydro-2,5,7,8-tetramethyl- 2-[(4R,8R)-4,8,12-trimethyltridecyl]- 2H-1-benzopyran-6-yl acetate,(1R,5R,17R)-17-hydroxy-1-methylandrostan- 3-one,magnesium di-3-pyridinecarboxylate and strychnidin-10-one mononitrate (8067-17-2)
Identification |
Properties |
Safety Data |
|
|
Other Product
- Yohimban-16-carboxylic acid,17-hydroxy-,methyl ester,monohydrochloride,(16R,17R)-,mixt. with (2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,- 8R)-4,8,12-trimethyltridecyl]-2H-1- benzopyran-6-yl acetate,3-pyridinecarboxamide and Tribestan
- D-Gluconic acid,calcium salt (2:1),mixt. with rel-(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2- [(4R,8R)-4,8,12-trimethyltridecyl]-2H-1- benzopyran-6-yl acetate,N-(1-methylethyl)-2-propanamine dichloroacetate and (17R)-19-norpregn-4-en-17-ol
- Yohimban-16-carboxylic acid,17-hydroxy-,methyl ester,(3â,16R,17R,20R)-
- Yohimban-16-carboxylic acid,17-hydroxy-11-methoxy-,methyl ester,(3â,16â,17R,20R)-
- Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with rel-3-(aminosulfonyl)-4-chloro-N-[(2R,6S)- 2,6-dimethyl-1-piperidinyl]benzamide and (5'R)-12'-hydroxy-2'-(1-methylethyl)-5'- (phenylmethyl)ergotaman-3',6',18-trione monomethanesulfonate (salt)
- L-Methionine,compounds,mixt. with L-cysteine,L-cystine,(2R)-3,4-dihydro-2,5,7,8-tetramethyl- 2-[(4R,8R)-4,8,12-trimethyltridecyl]- 2H-1-benzopyran-6-yl acetate,N-[(2R)-2,4-dihydroxy-3,3-dimethyl-1- oxobutyl]-â-alanine calcium salt (2:1),(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,- 4-d]imidazole-4-pentanoic acid,5-hydroxy-6-methyl-3,4-pyridinedimethanol,millet and riboflavin
- Androst-4-en-3-one,17-hydroxy-,(17â)-,mixt. with 3,7-dihydro-7-(2-hydroxyethyl)-1,- 3-dimethyl-1H-purine-2,6-dione,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,(17â)-10-ethyl-17-hydroxyestr-4-en- 3-one,4-hydroxy-R-[1-[(1-methyl-3-phenylpropyl) amino]ethyl]benzenemethanol hydrochloride and (17R)-19-norpregna-1,3,5(10)-trien-20-yne- 3,17-diol
- Androst-4-en-3-one,17-hydroxy-,(17â)-,mixt. with 3,7-dihydro-7-(2-hydroxyethyl)-1,- 3-dimethyl-1H-purine-2,6-dione,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,(17â)-10-ethyl-17-hydroxyestr-4-en- 3-one,4-hydroxy-R-[1-[(1-methyl-3-phenylpropyl) amino]ethyl]benzenemethanol hydrochloride and (17R)-19-norpregna-1,3,5(10)-trien-20-yne- 3,17-diol
- Yohimban-16-carboxylic acid,18-hydroxy-17-methoxy-,(3â,16â,17R,- 18â,20R)-
- [(2R,3S,4R,6S)-4-dimethylamino-2-[[(1S,2E,5R,7R,8R,9S,10R,14S,15R,16R) -14-ethyl-10-hydroxy-1,5,9,15-tetramethyl-4,12-dioxo-7-(2-oxoethyl)-13 ,17-dioxabicyclo[14.1.0]heptadec-2-en-8-yl]oxy]-6-methyl-oxan-3-yl] bu tanoate
- Butanedioic acid,esters,mono[(2R)-3,4- dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,- 12-trimethyltridecyl]-2H-1-benzopyran-6-yl] ester,mixt. with selenious acid
- [(3R,5R,8R,9S,10S,12S,13R,14S,17R)-12-acetyloxy-17-[(2R)-4-hydroxybutan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
- (5S,8R,9S,10S,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,1 6-trimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]p henanthren-3-one
- Pregn-4-ene-21-carboxylic acid,7-(acetylthio)-17-hydroxy-3-oxo-,ç- lactone,(7R,17R)-,mixt. with 3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide
- (4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-12-oxo-1,2,3,4,5,6,7,8,9,11,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
- Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with 6-chloro-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide and 2,3-dihydro-1,4-phthalazinedione dihydrazone sulfate (1:1)
- Pregna-4,6-diene-21-carboxylic acid,17-hydroxy-3-oxo-,monopotassium salt,(17R)-,mixt. with 6-chloro-3,4-dihydro-3-(2-methylpropyl)- 2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
- 18,19-Dinorpregn-4-en-20-yn-3-one,13- ethyl-17-hydroxy-,(17R)-(()-,mixt. with (17â)-3-hydroxyestra-1,3,5(10)-trien-17-yl pentanoate
- but-2-enedioic acid; (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenyl-ethoxy]ethyl]-1-methyl-pyrrolidine; (8S,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
- 2H-1-Benzopyran-2-one,7-[[(2Z)-5-[(1R,2R,- 5S,8R)-2-hydroxy-1,5-dimethyl-6-oxabicyclo- [3.2.1]oct-8-yl]-3-methyl-2-pentenyl]oxy]-